{"id":44064,"date":"2022-05-18T15:01:29","date_gmt":"2022-05-18T13:01:29","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/marinus-pharmaceuticals-to-present-at-upcoming-medical-and-investor-conferences\/"},"modified":"2022-05-18T15:01:29","modified_gmt":"2022-05-18T13:01:29","slug":"marinus-pharmaceuticals-to-present-at-upcoming-medical-and-investor-conferences","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/marinus-pharmaceuticals-to-present-at-upcoming-medical-and-investor-conferences\/","title":{"rendered":"Marinus Pharmaceuticals to Present at Upcoming Medical and Investor Conferences"},"content":{"rendered":"
\n

RADNOR, Pa.–(BUSINESS WIRE)–$MRNS<\/a> #MarinusPharma<\/a>—Marinus Pharmaceuticals, Inc.<\/a> (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today announced that management will participate in the following investor and medical conferences in May and June:\n<\/p>\n

<\/a><\/p>\n

\nCiti Biotech Virtual Co-Panel Day
\n
<\/b>May 18 <\/sup>at 3:30 p.m. ET.
\n
This presentation will be closed to conference participants only.\n<\/p>\n

\nH.C. Wainwright Global Investment Conference
\n
<\/b>Available on demand starting May 24 <\/sup>at 7:00 a.m. ET.
\n
Webcast Link:<\/b> https:\/\/journey.ct.events\/view\/f447a79f-2d56-40f1-9924-e6b53707d9c1<\/a>\n<\/p>\n

\nJefferies Global Healthcare Conference
\n
<\/b>June 9 <\/sup>at 3:30 p.m. ET in New York, N.Y.
\n
Webcast Link:<\/b> https:\/\/wsw.com\/webcast\/jeff240\/mrns\/1869600<\/a>\n<\/p>\n

\n16th EILAT Conference on New Antiepileptic Drugs and Devices
\n
<\/b>May 22 \u2013 25 in Madrid, Spain
\n
This event is closed to conference participants only.\n<\/p>\n

\nEpilepsy Foundation Pipeline Conference
\n
<\/b>June 6 <\/sup>at <\/sup>6:20 p.m. ET \/ 3:20 p.m. PT in Santa Clara, Calif.
\n
This presentation will be closed to conference participants only.\n<\/p>\n

\nAbout Marinus Pharmaceuticals
\n
<\/b>Marinus is a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders. Ganaxolone is a neuroactive steroid GABAA<\/sub> receptor modulator that acts on a well-characterized target in the brain known to have anti-seizure effects. It is being developed in IV and oral dose formulations intended to maximize therapeutic reach to adult and pediatric patient populations in both acute and chronic care settings. For more information visit www.marinuspharma.com<\/a>.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nSasha Damouni Ellis
\n
Vice President, Corporate Affairs & Investor Relations
\n
Marinus Pharmaceuticals, Inc.
\n
484-253-6792
\n
sdamouni@marinuspharma.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

RADNOR, Pa.–(BUSINESS WIRE)–$MRNS #MarinusPharma—Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today announced that management will participate in the following investor and medical conferences in May and June: Citi Biotech Virtual Co-Panel Day May 18 at 3:30 p.m. ET. This presentation will be closed … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-44064","6":"format-standard","7":"category-industry"},"yoast_head":"\nMarinus Pharmaceuticals to Present at Upcoming Medical and Investor Conferences - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/marinus-pharmaceuticals-to-present-at-upcoming-medical-and-investor-conferences\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Marinus Pharmaceuticals to Present at Upcoming Medical and Investor Conferences - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"RADNOR, Pa.–(BUSINESS WIRE)–$MRNS #MarinusPharma—Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today announced that management will participate in the following investor and medical conferences in May and June: Citi Biotech Virtual Co-Panel Day May 18 at 3:30 p.m. ET. This presentation will be closed ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/marinus-pharmaceuticals-to-present-at-upcoming-medical-and-investor-conferences\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-05-18T13:01:29+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220518005448\/en\/1459539\/21\/marinus-color.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/marinus-pharmaceuticals-to-present-at-upcoming-medical-and-investor-conferences\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/marinus-pharmaceuticals-to-present-at-upcoming-medical-and-investor-conferences\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Marinus Pharmaceuticals to Present at Upcoming Medical and Investor Conferences\",\"datePublished\":\"2022-05-18T13:01:29+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/marinus-pharmaceuticals-to-present-at-upcoming-medical-and-investor-conferences\\\/\"},\"wordCount\":268,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/marinus-pharmaceuticals-to-present-at-upcoming-medical-and-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220518005448\\\/en\\\/1459539\\\/21\\\/marinus-color.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/marinus-pharmaceuticals-to-present-at-upcoming-medical-and-investor-conferences\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/marinus-pharmaceuticals-to-present-at-upcoming-medical-and-investor-conferences\\\/\",\"name\":\"Marinus Pharmaceuticals to Present at Upcoming Medical and Investor Conferences - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/marinus-pharmaceuticals-to-present-at-upcoming-medical-and-investor-conferences\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/marinus-pharmaceuticals-to-present-at-upcoming-medical-and-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220518005448\\\/en\\\/1459539\\\/21\\\/marinus-color.jpg\",\"datePublished\":\"2022-05-18T13:01:29+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/marinus-pharmaceuticals-to-present-at-upcoming-medical-and-investor-conferences\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/marinus-pharmaceuticals-to-present-at-upcoming-medical-and-investor-conferences\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/marinus-pharmaceuticals-to-present-at-upcoming-medical-and-investor-conferences\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220518005448\\\/en\\\/1459539\\\/21\\\/marinus-color.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220518005448\\\/en\\\/1459539\\\/21\\\/marinus-color.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/marinus-pharmaceuticals-to-present-at-upcoming-medical-and-investor-conferences\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Marinus Pharmaceuticals to Present at Upcoming Medical and Investor Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Marinus Pharmaceuticals to Present at Upcoming Medical and Investor Conferences - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/marinus-pharmaceuticals-to-present-at-upcoming-medical-and-investor-conferences\/","og_locale":"en_US","og_type":"article","og_title":"Marinus Pharmaceuticals to Present at Upcoming Medical and Investor Conferences - Pharma Trend","og_description":"RADNOR, Pa.–(BUSINESS WIRE)–$MRNS #MarinusPharma—Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today announced that management will participate in the following investor and medical conferences in May and June: Citi Biotech Virtual Co-Panel Day May 18 at 3:30 p.m. ET. This presentation will be closed ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/marinus-pharmaceuticals-to-present-at-upcoming-medical-and-investor-conferences\/","og_site_name":"Pharma Trend","article_published_time":"2022-05-18T13:01:29+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220518005448\/en\/1459539\/21\/marinus-color.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/marinus-pharmaceuticals-to-present-at-upcoming-medical-and-investor-conferences\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/marinus-pharmaceuticals-to-present-at-upcoming-medical-and-investor-conferences\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Marinus Pharmaceuticals to Present at Upcoming Medical and Investor Conferences","datePublished":"2022-05-18T13:01:29+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/marinus-pharmaceuticals-to-present-at-upcoming-medical-and-investor-conferences\/"},"wordCount":268,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/marinus-pharmaceuticals-to-present-at-upcoming-medical-and-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220518005448\/en\/1459539\/21\/marinus-color.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/marinus-pharmaceuticals-to-present-at-upcoming-medical-and-investor-conferences\/","url":"https:\/\/pharma-trend.com\/en\/marinus-pharmaceuticals-to-present-at-upcoming-medical-and-investor-conferences\/","name":"Marinus Pharmaceuticals to Present at Upcoming Medical and Investor Conferences - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/marinus-pharmaceuticals-to-present-at-upcoming-medical-and-investor-conferences\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/marinus-pharmaceuticals-to-present-at-upcoming-medical-and-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220518005448\/en\/1459539\/21\/marinus-color.jpg","datePublished":"2022-05-18T13:01:29+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/marinus-pharmaceuticals-to-present-at-upcoming-medical-and-investor-conferences\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/marinus-pharmaceuticals-to-present-at-upcoming-medical-and-investor-conferences\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/marinus-pharmaceuticals-to-present-at-upcoming-medical-and-investor-conferences\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220518005448\/en\/1459539\/21\/marinus-color.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220518005448\/en\/1459539\/21\/marinus-color.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/marinus-pharmaceuticals-to-present-at-upcoming-medical-and-investor-conferences\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Marinus Pharmaceuticals to Present at Upcoming Medical and Investor Conferences"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/44064","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=44064"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/44064\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=44064"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=44064"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=44064"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}